Skip to main content
Signal8

Hypha Labs, Inc. (FUNI)

Sector: Services-Testing Laboratories

Industry: Medical - Diagnostics & Research

Hypha Labs, Inc. logo

Hypha Labs, Inc.

OTC:FUNIHealthcare
AH-2.22%$0.0044
Close$0.0045+8.12%
Mkt Cap$738K
Float150.57M
O/S163.9M
VOL48K sh
$ Vol$204
RVOL1.23×
Inst Own-
SI<0.1%
Dilution
Hypha Labs, Inc. logoOTC:FUNIAH$0.0044-2.22%
Historical Data
DateOpenHighLowCloseVolume
Nov 4, 20260.00370.00450.00370.004548,464
Nov 3, 20260.00450.00450.00400.0042125,000
Nov 2, 20260.00410.00410.00350.003525,000
Oct 30, 20260.00230.00230.00230.00231,000
Oct 29, 20260.00230.00340.00230.003419,000
Oct 28, 20260.00410.00410.00230.0036110,000
Oct 27, 20260.00370.00370.00370.00376,366
Oct 23, 20260.00440.00450.00440.004557,920
Oct 21, 20260.00440.00450.00440.004585,000
Oct 20, 20260.00430.00430.00430.0043443
Oct 19, 20260.00420.00420.00420.00421,000
Oct 16, 20260.00440.00440.00440.004410,057
Oct 14, 20260.00400.00400.00400.00402,518
Oct 13, 20260.00400.00420.00400.00424,708
Oct 9, 20260.00420.00420.00390.00422,840
Oct 8, 20260.00420.00420.00400.00408,206
Oct 7, 20260.00460.00460.00400.004011,000
Oct 6, 20260.00430.00460.00410.0046200,977
Oct 5, 20260.00460.00460.00440.004450,000
Oct 2, 20260.00410.00450.00400.0045236,997
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
InsiderTypeShares
DOUGLASS A STONE profile photoDOUGLASS A STONEGrant/Award4.00M
DOUGLASS A STONE profile photoDOUGLASS A STONEGrant/Award2.00M
Shareholders
0.0%
Institutional
(0)
4.6%
Insiderⓘ
(1)
0.0%
5%+ Owners
(0)
95.4%
Unattributed (incl. retail)ⓘ
Insider4.6%
Unattributed (incl. retail)95.4%
Top Shareholders
Sources: Form 4O/S: 163.9M · as of 14 Aug 2026 · SEC filings
Insiders & Institutional Holders

Insiders

About

Hypha Labs, Inc. focuses on the investigation, development, and market release of bioreactor systems across the United States. Their key offering is the Hypha Micropearl bioreactor, a specialized household device engineered to rapidly cultivate beneficial mushrooms for dietary intake. Founded in 2010, the company is officially based in Las Vegas, Nevada.

Key Metrics
Market Cap$737,532
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryMedical - Diagnostics & Research
ExchangeOTC
CountryUSUS
IPO DateAug 13, 2012
Shares Outstanding163.90M
Float150.57M
52-Week Range
$0.0023$0.0400
$0.0045(6th percentile)
Volume
Average Daily Volume39.47K
48.46K today vs 39.47K avg(+23%)

30d Avg

39.47K

60d Avg

118.31K

90d Avg

373.80K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...